Except for SLC22A7, the expression levels of SLC22A6, SLC22A13, SLC25A4, SLC34A1, and SLC44A4 were correlated with the clinical stage of ccRCC patients. This evidence concerns the gene SLC44A4 and nonpapillary renal cell carcinoma.